ABCA1 and age-related macular degeneration: The work by Guay et al. and Sene et al. suggest that manipulating the ABCA1 promoter methylation levels may be an alternative approach for increasing or restoring ABCA1 function and potentially reducing incidences of both CAD and AMD.